Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABROCITINIB vs ACARBOSE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABROCITINIB vs ACARBOSE: Safety Overview

Metric ABROCITINIB ACARBOSE
Total FAERS Reports 3,170 1,770
Deaths Reported 57 84
Death Rate 1.8% 4.7%
Hospitalizations 329 915
Average Patient Age 48.5 yrs 65.9 yrs
% Female Patients 53.9% 55.0%
FDA Approval Date Jan 14, 2022 Aug 18, 2020
Manufacturer U.S. Pharmaceuticals Strides Pharma Science Limited
Route ORAL ORAL
Marketing Status Prescription Discontinued